[Possibility of inducing the adaptive response of cells to exposure to ionizing radiation]
Related Experiment Videos
Abstract:
Mechanisms of induction of the antimutagenic and anticarcinogenic adaptive repair response of cells to the effect of alkylating substances and other genotoxic agents are discussed. The possibility of induction of adaptive repair response of mammalian cells to low-level radiation is suggested.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[On the prospects of using the DNA repair inhibitors in radiotherapy of tumors].
Radiatsionnaia biologiia, radioecologiia·2015
[Experimental detection of integration of mTDNA in the nuclear genome induced by ionizing radiation].
Radiatsionnaia biologiia, radioecologiia·2014
[Pathways for maintenance of mitochondrial DNA integrity and mitochondrial functions in cells exposed to ionizing radiation].
Radiatsionnaia biologiia, radioecologiia·2013
[Variability of DNA simple sequence repeats in peripheral blood of humans subjected to prolonged exposures of ionizing radiation].
Radiatsionnaia biologiia, radioecologiia·2013
[Changes of mitochondrial DNA/nuclear DNA ratio in the blood serum following X-ray irradiation of mice at various doses].
Radiatsionnaia biologiia, radioecologiia·2013
[Low efficiency of repair of critical DNA damage induced by low doses of radiation].
Radiatsionnaia biologiia, radioecologiia·2012
A cell-type resolved proton RBE model for potential clinical application.
Medical physics·2026
Adaptive MR-guided whole-pelvic SBRT with or without focal intraprostatic lesion boost for high-risk localized prostate Cancer: Adverse events and longitudinal quality-of-life outcomes.
Clinical and translational radiation oncology·2026
Development and validation of a cumulative risk model and assessment tool for radiation-induced hypothyroidism in head and neck cancer: a multicentre study.
Clinical and translational radiation oncology·2026
Radiation therapy quality assurance (RT QA) of adjuvant fractionated radiotherapy for WHO grade 2 atypical meningioma in the ROAM/EORTC1308 trial.
Clinical and translational radiation oncology·2026